Literature DB >> 26768714

Biology of Bone Metastases in Prostate Cancer.

Janine Hensel1, George N Thalmann2.   

Abstract

Advanced-stage prostate cancer (PCa) patients are often diagnosed with bone metastases. Bone metastases remain incurable and therapies are palliative. PCa cells prevalently cause osteoblastic lesions, characterized by an excess of bone formation. The prevailing concept indicates that PCa cancer cell secrete an excess of paracrine factors stimulating osteoblasts directly or indirectly, thereby leading to an excess of bone formation. The exact mechanisms by which bone formation stimulates PCa cell growth are mostly elusive. In this review, the mechanisms of PCa cancer cell osteotropism, the cancer cell-induced response within the bone marrow/bone stroma, and therapeutic stromal targets will be summarized.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26768714     DOI: 10.1016/j.urology.2015.12.039

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  28 in total

1.  The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.

Authors:  Jung-Jin Park; Mee-Hee Park; Eun Hye Oh; Nak-Kyun Soung; Soo Jae Lee; Jae-Kyung Jung; Ok-Jun Lee; Seok Joong Yun; Wun-Jae Kim; Eun-Young Shin; Eung-Gook Kim
Journal:  Oncogene       Date:  2018-05-30       Impact factor: 9.867

Review 2.  Metastases in Prostate Cancer.

Authors:  Federico La Manna; Sofia Karkampouna; Eugenio Zoni; Marta De Menna; Janine Hensel; George N Thalmann; Marianna Kruithof-de Julio
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

Review 3.  Role of prostate and bone stromal cells on prostate cancer progression.

Authors:  Sofia Karkampouna; Marianna Kruithof-de Julio; George N Thalmann
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

4.  PAK1 inhibitor IPA-3 mitigates metastatic prostate cancer-induced bone remodeling.

Authors:  Arti Verma; Sandeep Artham; Abdulrahman Alwhaibi; Mir S Adil; Brian S Cummings; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2020-03-30       Impact factor: 5.858

Review 5.  Osteoblastic Factors in Prostate Cancer Bone Metastasis.

Authors:  Song-Chang Lin; Li-Yuan Yu-Lee; Sue-Hwa Lin
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

Review 6.  Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.

Authors:  Eva C González Díaz; Sauradeep Sinha; Raffi S Avedian; Fan Yang
Journal:  Acta Biomater       Date:  2019-08-13       Impact factor: 8.947

7.  Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.

Authors:  Wenchu Wang; Xin Yang; Jinlu Dai; Yi Lu; Jian Zhang; Evan T Keller
Journal:  Oncogene       Date:  2019-02-12       Impact factor: 8.756

8.  The role of microRNAs in bone metastasis.

Authors:  Eugenio Zoni; Gabri van der Pluijm
Journal:  J Bone Oncol       Date:  2016-07-08       Impact factor: 4.072

9.  Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation.

Authors:  Terese Karlsson; Marie Lundholm; Anders Widmark; Emma Persson
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

Review 10.  A systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario?

Authors:  Francesca Salamanna; Deyanira Contartese; Melania Maglio; Milena Fini
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.